痰热清注射液联合头孢哌酮-舒巴坦治疗老年社区获得性肺炎的疗效评价

目的观察痰热清注射液联合头孢哌酮-舒巴坦治疗老年社区获得性肺炎（CAP）的临床效果和安全性。方法78例CAP患者随机分为治疗组（40例）和对照组（38例）。对照组采用头孢哌酮-舒巴坦治疗，治疗组在对照组治疗的基础上加用痰热清注射液静脉滴注治疗，共治疗10d。治疗结束后评价临床疗效、细菌学疗效和安全性。结果治疗组临床疗效有效率为92．5％，高于对照组（81．6％），相比较差异有显著性（P〈0．05）；治疗组细菌清除率为93．9％，高于对照组（80．6％），相比较差异有显著性（P〈0．05）；治疗组不良反应发生率为12．5％，低于对照组（76．3％），相比较有显著性差异（P〈0．05）。结论痰热清注射液联合头孢哌酮-舒巴坦治疗CAP安全、有效，值得临床推广应用。

Curative effect of combined treatment of tanreqing injection and cefoperazone-sulbactam for community acquired pneumonia

Objective To observe the curative effects and safety of the combined treatment of tanreqing injection and cefoperazone-sulbactam for community acquired pneumonia(CAP).Methods Seventy-eight cases of CAP were divided randomly into treatment group(40 cases)and control group(38 cases).The control group was treated with cefoperazone-sulbactam,while combined treatment of tanreqing injection and cefoperazone-sulbactam were taken in treatment group.The total treatment course was 10 days.Clinical efficacy,bacteriolo...